Paper39155333
Association of fibrotic markers with diastolic function after STEMI.
Al Ali L and 9 others. Sci Rep, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Association of fibrotic markers with diastolic function after STEMI. Papers, record 39155333. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39155333
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ST Elevation Myocardial Infarction | Major topic |
| Biomarkers | Major topic |
| Interleukin-1 Receptor-Like 1 Protein | Major topic |
| Diastole | Major topic |
| Fibrosis | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Aged | |
| Galectin 3 | |
| Galectins | |
| Prognosis | |
| Echocardiography | |
| Follow-Up Studies | |
| Blood Proteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 95103007 | ZonMw,Netherlands | PubMed |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27324127 | Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. | Cell Tissue Res | 2016 | https://conductscience.org/library/papers/27324127 | PubMed |
| 2 | 18827826 | The IL-33/ST2 pathway: therapeutic target and novel biomarker. | Nat Rev Drug Discov | 2008 | https://conductscience.org/library/papers/18827826 | PubMed |
| 3 | 12578875 | Identification of serum soluble ST2 receptor as a novel heart failure biomarker. | Circulation | 2003 | https://conductscience.org/library/papers/12578875 | PubMed |
| 4 | 7573347 | Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. | Am J Pathol | 1995 | https://conductscience.org/library/papers/7573347 | PubMed |
| 5 | 15520318 | Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. | Circulation | 2004 | https://conductscience.org/library/papers/15520318 | PubMed |
| 6 | 24890535 | Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials. | Am Heart J | 2014 | https://conductscience.org/library/papers/24890535 | PubMed |
| 7 | 22026577 | The fibrosis marker galectin-3 and outcome in the general population. | J Intern Med | 2012 | https://conductscience.org/library/papers/22026577 | PubMed |
| 8 | 26528636 | Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction. | Clin Chim Acta | 2016 | https://conductscience.org/library/papers/26528636 | PubMed |
| 9 | 22968678 | Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial. | Cardiovasc Drugs Ther | 2012 | https://conductscience.org/library/papers/22968678 | PubMed |
| 10 | 24687169 | Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. | JAMA | 2014 | https://conductscience.org/library/papers/24687169 | PubMed |
| 11 | 27977774 | The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction. | PLoS One | 2016 | https://conductscience.org/library/papers/27977774 | PubMed |
| 12 | 24606321 | The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure. | Expert Rev Mol Diagn | 2014 | https://conductscience.org/library/papers/24606321 | PubMed |
| 13 | 20153309 | Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure. | Clin Biochem | 2010 | https://conductscience.org/library/papers/20153309 | PubMed |
| 14 | 23256700 | The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2. | Expert Rev Mol Diagn | 2013 | https://conductscience.org/library/papers/23256700 | PubMed |
| 15 | 19270053 | Recommendations for the evaluation of left ventricular diastolic function by echocardiography. | Eur J Echocardiogr | 2009 | https://conductscience.org/library/papers/19270053 | PubMed |
| 16 | 16458610 | Recommendations for chamber quantification. | Eur J Echocardiogr | 2006 | https://conductscience.org/library/papers/16458610 | PubMed |
| 17 | 2936235 | Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. | Am J Cardiol | 1986 | https://conductscience.org/library/papers/2936235 | PubMed |
| 18 | 31504452 | How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). | Eur Heart J | 2019 | https://conductscience.org/library/papers/31504452 | PubMed |
| 19 | 20221616 | Diastolic function measurements and diagnostic consequences: a comparison of pulsed wave- and color-coded tissue Doppler imaging. | Clin Res Cardiol | 2010 | https://conductscience.org/library/papers/20221616 | PubMed |
| 20 | 30980045 | Redefine statistical significance. | Nat Hum Behav | 2018 | https://conductscience.org/library/papers/30980045 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41322482 | Predictive value of dynamic changes in RvD1, sST2, and PIV levels for the prognosis of STEMI patients after PCI: a prospective study. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41322482 | PubMed |
| 39950330 | The role of autophagy in fibrosis: Mechanisms, progression and therapeutic potential (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/39950330 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| LGALS3 | 3958 | PubTator's text mining | https://conductscience.org/library/genes/3958 | NCBI Gene |
| ST2 | 6761 | PubTator's text mining | https://conductscience.org/library/genes/6761 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39155333
GET https://conductscience.org/api/papers/v1/39155333/references?page=2